| 2024 | ||
|---|---|---|
| Gross margin | 111,4 k € | |
| EBITDA | -4,6 k € | |
| Operating profit | -330,3 k € | |
| Profit/loss | -341,7 k € | |
| Equity | -331,7 k € | |
| Total assets | 160,1 k € | |
| Cash | 123,4 k € | |
| Debts | 491,8 k € | |
| Staff | 1,6 | |
Source: Belgian Official Gazette
Private limited company · Gent · incorporated on 13/07/2023 · 1,6 ETP
Company — Opening of bankruptcy.
Private limited company loss-making in the latest fiscal year.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
Amalus Therapeutics is a Private limited company incorporated in 2023. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Gent. It employs on average 1,6 ETP workers (FTE).